SARASOTA, Fla., June 22, 2006 (PRIMEZONE) -- DNAPrint Genomics, Inc. (OTCBB:DNAG) President and Chief Executive Officer Richard Gabriel told shareholders at the Annual Meeting today that the ...

SARASOTA -- A genetics test owned by DNAPrint Genomics Inc. helped lead investigators to a suspect in a string of Louisiana murders. Authorities arrested Derrick T. Lee in Atlanta last week in ...

DNAPrint Genomics Inc. Annual stock financials by MarketWatch. View the latest DNAG financial statements, income statements and financial ratios.

The German partner of DNAPrint Genomics Inc. has the go-ahead to begin its first human study of a drug intended to prevent migraine headaches. Biofrontera AG, in which DNAPrint owns a nearly 10 ...

DNAPrint genomics Inc. said it would acquire some of the assets of Ellipsis Biotherapeutics Corp. in a stock deal valued at about $112,000. Ellipsis will sell its clinical genomics and genotyping ...

DNAPrint Genomics, Inc. has announced the expansion of the Company’s high-throughput genotyping capacity from 1.3 million to 3.9 million genotypes per day. "Multiplexing and advanced automation ...

DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that representatives of Ellipsis Biotherapeutics Corporation, a wholly owned subsidiary of DNAPrint Genomics, will exhibit at the American Society ...

In our ongoing attempt to adhere to the public schedule, I would like to introduce the next company in this afternoon’s program. DNAPrint is a biotechnology company dedicated to the development of ...

SARASOTA, June 16, 2006 (PRIMEZONE) -- DNAPrint Genomics, Inc. (OTCBB:DNAG) today announced that a newspaper columnist's quest to unravel an old family mystery was solved with a Father's Day gift -- ...

DNAPrint Genomics, Inc. engages in the research and development of genomics-based products and services for biomedical and forensics. The company was founded by Tony N. Frudakis on January 3, 1983 and ...